During the past decade, Hospital Amaral Carvalho conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 30 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 18 clinical trials were completed. i.e. 105.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Amaral Carvalho" #1 sponsor was "Hoffmann-La Roche" with 17 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Takeda" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Eurofarma Laboratorios S.A." with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Amaral Carvalho" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Amaral Carvalho" are "Breast Cancer" (5 trials), "Multiple Myeloma" (4 trials), "Head and Neck Cancer" (3 trials), "Metastatic Breast Cancer" (3 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Hospital Amaral Carvalho" in a lesser frequency.

Most popular intervention types in "Hospital Amaral Carvalho" are "Drug" (58 trials), "Other" (7 trials), "Biological" (6 trials), "Radiation" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Docetaxel" (8 trials), "Carboplatin" (7 trials), "Paclitaxel" (6 trials) and "Trastuzumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Amaral Carvalho" are 51 trials for "All" genders, 9 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Amaral Carvalho". undefined are not yet recruiting, 14 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Hospital Amaral Carvalho, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Amaral Carvalho, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".